FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US, Authority Hl7

16,400 resources

Type: Text:

By Version

 

Start Prev Rows 13200 - 13400 Next

PackageVersionIdentityName/TitleStatusFMMWGDate
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1019Diseases of Urinary Systemactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1301Surgery Integumentary System Breastactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1302Surgery Respiratory System Accessory Sinusesactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1303Surgery Respiratory System Larynxactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1304Surgery Respiratory System Trachea and Bronchiactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1305Surgery Respiratory System Lungs and Pleuraactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13064Surgery Digestive System Esophagusactive2020-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1307Surgery Digestive System Intestines (Except Rectum)active2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1308Surgery Digestive System Rectumactive2019-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1309Surgery Digestive System Anusactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1310Surgery Digestive System Biliary Tractactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1311Surgery Digestive System Abdomen Peritoneum Omentumactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1312Surgery Digestive System Kidneyactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13133Surgery Digestive System Ureteractive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1314Surgery Digestive System Bladderactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1315Surgery Female Genital System Cervix Uteriactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1316Surgery Female Genital System Corpus Uteriactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1317Surgery Female Genital System Oviduct Ovaryactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1318Surgery Eye and Ocular Adnexa Anterior Segmentactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13193Other Surgeriesactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13202SPECT MPIactive2020-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13213Stress Echocardiographyactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13222Stress MRIactive2020-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1323CCTAactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1329Diabetes Mellitusactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1330Renal insufficiencyactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1331Stroke transient ischemic attackactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1332Prior heart failureactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1333Ischemic heart diseaseactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1804Claim(s) for evaluation and management > 28 days and <60 days preceding the lumbar spine MRIactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.18143Patients with lumbar spine surgery in the 90 days prior to MRIactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1832Canceractive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1838Neoplastic abnormalitiesactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1839Treatment fields for radiation therapyactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1842Postoperative fluid collections and soft tissue changesactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1847Unspecified Immune Deficienciesactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1833Congenital spine and spinal cord malformationsactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1834Inflammatory and autoimmune disordersactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1835Infectious conditionsactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1836Spinal vascular malformations and/or the cause of occult subarachnoid hemorrhageactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1837Spinal cord infarctionactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1840Spinal abnormalities associated with scoliosisactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1841Syringohydromyeliaactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1844IV Drug Abuseactive2022-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1845Neurological Impairmentactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1846Human Immunodeficiency Virusactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1843Traumaactive2020-07
signal.core.r4R4ValueSet/observation-categoryObservation Category Codesdraft1oo2019-10
hl7.fhir.us.vdorR4ValueSet/vdor-toxicology-summary-tests-vsVDOR Toxicology Summary Tests Value Setinformativepher2025-06
hl7.fhir.us.breast-radiologyR4ValueSet/ObservedChangesVSObservedChanges ValueSetactive2022-12
fhir.cdc.opioid-cds-r4R4ValueSet/synthetic-opioid-medicationsSynthetic opioid medicationsactive2023-05
hl7.fhir.us.carin-bbR4ValueSet/OralBodySiteOral Body Site Value Settrial-usefm2025-02
hl7.fhir.us.haiR4ValueSet/nhsn-pathogen-rankingNHSNPathogenRankingactive2023-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1237.13SNOMED Organism from LOINC Answer Listactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1010.8Vaccine Clinical Drugactive2024-06
fhir.giisR4ValueSet/OtherVaccineVSOther Vaccine codesdraft2025-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.86Pregnancy Outcomeactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.4436Gentamicin medicationsactive2024-05
hl7.fhir.us.registry-protocolsR4ValueSet/PCIOperatorPCI Operator SNOMED codesactivecic2023-11
ca.on.dhdr.r4.v4R4ValueSet/encounter-participant-typeEncounter Participant Typeactive2019-02
hl7.fhir.us.registry-protocolsR4ValueSet/PatientCenteredReasonforDelayPatient Centered Reason for Delayactivecic2023-11
fhir.kenyaPSIGR4ValueSet/PatientContactRlshipVSPatient Contact Relationship ValueSetdraft2025-07
fhir.kenyaPSIGR4ValueSet/PatientIdentifierTypesVSPatient Identifier Types ValueSetdraft2025-07
fhir.giisR4ValueSet/AEFIPatientStatusVSPatient Status related to an AEFI codesdraft2025-07
fhir.kenyaPSIGR4ValueSet/PatientTitleVSPatient titledraft2025-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1045.66PCIactive2017-05
hl7.fhir.us.military-serviceR4ValueSet/military-service-paygrade-vsPay Grade Code Value Setactive2023-05
hl7.fhir.us.ndhR4ValueSet/NdhDirectTrustPayloadTypeVSNDH Direct Trust Payload Type Value Settrial-usepa2025-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.18Medication Drug Classactive2024-06
hl7.fhir.us.davinci-drug-formularyR4ValueSet/PharmacyBenefitTypeVSPharmacy benefit typestrial-usephx2025-02
signal.core.r4R4ValueSet/questionnaire-ccars-place-of-residenceQuestionnaire CCARS Place Of Residencedraft1pa
hl7.fhir.us.vrdrR4ValueSet/vrdr-place-of-injury-other-vsPlace of Injury - Other ValueSetactivepher2024-10
hl7.fhir.us.vrdrR4ValueSet/vrdr-place-of-injury-vsPlace of Injury ValueSetactivepher2024-10
hl7.fhir.us.carin-bbR4ValueSet/CMSPlaceofServiceCodesCMS Place of Service Codes (POS) Value Settrial-usefm2025-02
hl7.fhir.us.mcodeR4ValueSet/tg263-vsTG263 ValueSetactivecic2025-02
fhir.virtually.healthcareR4ValueSet/PractitionerIdentifiersPractitioner Identifiersdraft2025-07
fhir.nw-gmsa.nhs.ukR4ValueSet/PractitionerIdentifiersPractitioner Identifiersdraft2025-04
signal.core.r4R4ValueSet/condition-severityCondition/Diagnosis Severitydraftpc
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.84Other Pregnancy Outcomeactive2024-06
fhir.cdc.opioid-cds-r4R4ValueSet/barbiturate-urine-drug-screening-testsBarbiturate urine drug screening testsdraft2024-04
fhir.cdc.opioid-cds-r4R4ValueSet/benzodiazepine-urine-drug-screening-testsBenzodiazepine urine drug screening testsdraft2024-04
fhir.cdc.opioid-cds-r4R4ValueSet/buprenorphine-urine-drug-screening-testsBuprenorphine urine drug screening testsdraft2024-04
fhir.cdc.opioid-cds-r4R4ValueSet/heroin-urine-drug-screening-testsHeroin urine drug screening testsdraft2024-04
fhir.cdc.opioid-cds-r4R4ValueSet/general-opiate-urine-drug-screening-testsGeneral opiate urine drug screening testsactive2023-05
fhir.cdc.opioid-cds-r4R4ValueSet/oxycodone-urine-drug-screening-testsOxycodone urine drug screening testsdraft2024-04
hl7.fhir.us.vdorR4ValueSet/vdor-previous-overdose-timing-vsVDOR Previous Overdose Timinginformativepher2025-06
hl7.fhir.us.vdorR4ValueSet/vdor-previous-overdose-vsVDOR Previous Overdoseinformativepher2025-06
signal.core.r4R4ValueSet/questionnaire-ccars-previous-concurrent-servicesQuestionnaire CCARS Previous Concurrent Servicesdraft1pa
fhir.org.nz.ig.baseR4ValueSet/phoPHOactive2025-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1021.101Gender Identity USCDI coreactive2024-02
hl7.fhir.us.registry-protocolsR4ValueSet/PriorDiagnosticCoronaryAngiographyProcedureResultsPrior Diagnostic Coronary Angiography Procedure Resultsactivecic2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1010.2Clinical Substanceactive2024-06
fhir.cdc.opioid-cds-r4R4ValueSet/condition-problem-list-categoryProblem List Condition Categoryactive2023-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.7.4Problemactive2024-06
signal.core.r4R4ValueSet/procedure-categoryProcedure Category Codes (SNOMED CT)draft1pc2019-10
hl7.fhir.us.davinci-pctR4ValueSet/ICD10ProcedureCodesICD-10 Procedure Codestrial-usefm2025-06
fhir.cdc.opioid-cds-r4R4ValueSet/observation-category-procedureObservation Category Procedureactive2023-05
signal.core.r4R4ValueSet/procedure-outcomeProcedure Outcome Codes (SNOMED CT)draft1pc2019-10
fhir.cdc.opioid-cds-r4R4ValueSet/hospice-procedureHospice Procedureactive2023-05
signal.core.r4R4ValueSet/procedure-followupProcedure Follow up Codes (SNOMED CT)draft1pc2019-10
fhir.cdc.opioid-cds-r4R4ValueSet/pdmp-review-procedurePDMP review procedureactive2023-05
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-counseling-procedureOpioid counseling procedureactive2023-05
fhir.cdc.opioid-cds-r4R4ValueSet/pain-management-procedurePain management procedureactive2023-05
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-misuse-assessment-procedureOpioid misuse assessment procedureactive2023-05
hl7.fhir.us.birthdefectreportingR4ValueSet/bdr-procedurelistNewborn Procedure Listdraftpher2025-06
signal.core.r4R4ValueSet/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goalsQuestionnaire DACODS Discharge Progress Towards Measurable Treatment Goalsdraft1pa
signal.core.r4R4ValueSet/progress-made-towards-goalsProgress Made Towards Goalsdraft1pa
fhir.argonaut.pdR3ValueSet/provider-roleArgonaut Provider Directory Provider Role (NUCC)draft2016-08
fhir.argonaut.pdR3ValueSet/provider-specialtyArgonaut Provider Directory Provider Speciality (NUCC)draft2016-08
hl7.fhir.us.breast-radiologyR4ValueSet/rde1563-quadrantRDE1563 Quadrantdraft2022-12
hl7.fhir.us.davinci-drug-formularyR4ValueSet/CoinsuranceOptionVSQualifier for coinsurance ratetrial-usephx2025-02
hl7.fhir.us.Davinci-drug-formularyR4ValueSet/usdf-CoinsuranceOptionVSCoinsurance Option VSdraft2020-01
hl7.fhir.us.davinci-drug-formularyR4ValueSet/CopayOptionVSQualifier of copay amounttrial-usephx2025-02
hl7.fhir.us.Davinci-drug-formularyR4ValueSet/usdf-CopayOptionVSCopay Option VSdraft2020-01
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-disease-progression-qualifier-vsDisease Progression Qualifier Value Setactivecgp2025-02
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-intrafraction-verification-qualifier-vsIntrafraction Verification Procedure Qualifier Value Setactivecgp2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-body-location-qualifier-vsBody Location Qualifier Value Setactive4cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-body-location-and-laterality-qualifier-vsBody Location and Laterality Qualifier Value Setactive4cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-laterality-qualifier-vsLaterality Qualifier Value Setactive4cic2025-02
hl7.fhir.us.davinci-dtrR4ValueSet/MetricsinformationOriginsInformation Human Origins Value Settrial-use2cds2025-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.242RET Test (HGNC)active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.245RET Negative (geneinterpretaion) SNOMEDactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.244RET Gene Rearrangementactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.243RET Positive (Genei interpretation )active2024-06
signal.core.r4R4ValueSet/questionnaire-ccars-raceQuestionnaire CCARS Racedraft1pa
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188Radiotherapyactive2017-03
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.189Radiotherapyactive2017-03
hl7.fhir.us.mcodeR4ValueSet/mcode-rai-staging-method-vsRai Staging System Value Setactivecic2025-02
signal.core.r4R4ValueSet/questionnaire-ccars-overall-symptom-severity-ratingQuestionnaire CCARS Overall Symptom Severity Ratingdraft1pa
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1254.1EventTiming-TimingEventactive2024-05
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1254.2EventTiming-EventTimingactive2024-05
us.nlm.vsacR4ValueSet/event-timingEventTimingnormative5fhir2023-03
signal.core.r4R4ValueSet/reason-for-dischargeReason For Dischargeactive2023-06
hl7.fhir.us.davinci-raR4ValueSet/remark-reasonRemark Reasontrial-use2cqi2025-07
hl7.fhir.us.davinci-deqmR4ValueSet/remark-reasonRemark Reasontrial-use4cqi2025-07
fhir.nigeriaImmunizationR4ValueSet/NEIRImmunizationNotDoneReasonsVSReason Vaccine not administereddraft2025-05
hl7.fhir.us.davinci-crdR4ValueSet/coverageAssertionReasonsCRD Coverage Assertion Reasonstrial-use1fm2025-07
hl7.fhir.us.registry-protocolsR4ValueSet/PCIIndicationsPercutaneous Coronary Intervention Indicationactivecic2023-11
hl7.fhir.us.vdorR4ValueSet/vdor-recent-emergency-department-visit-vsVDOR Recent Emergency Department Visit or Urgent Care Visitinformativepher2025-06
hl7.fhir.us.military-serviceR4ValueSet/military-service-deployment-episode-mission-vsDeployment Episode Type Value Setactive2023-05
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113883.1.11.20.2.3ReferralDocumentTypetrial-usecgp2018-05
hl7.fhir.us.breast-radiologyR4ValueSet/rde1564-regionRDE1564 Regiondraft2022-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.115Self Identified Need for Contraception (SINC)active2021-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1010.9Substance Other Than Clinical Drugactive2024-06
hl7.fhir.us.vrdrR4ValueSet/vrdr-replace-status-vsReplacement Status ValueSetactivepher2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.231Gestational Diabetes ICD10CMactive2023-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20.12HealthStatusactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1210Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results)active2023-01
hl7.fhir.us.dafR3ValueSet/daf-research-data-modelsDAF Research Data Modelsactive2016-07
hl7.fhir.us.dafR3ValueSet/daf-research-query-formatsDAF Research Query Formatsactive2016-07
hl7.fhir.us.davinci-crdR4ValueSet/coverageClassCRD Coverage Classes Value Settrial-use4fm2025-07
fhir.virtually.healthcareR4ValueSet/PatientReferralPatient Referraldraft2025-07
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-distant-metastases-category-vsTNM Distant Metastases Category Value Setactive4cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-regional-nodes-category-vsTNM Regional Nodes Category Value Setactive4cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-primary-tumor-category-vsTNM Primary Tumor Category Value Setactive4cic2025-02
hl7.fhir.us.mcodeR4ValueSet/mcode-tnm-stage-group-vsTNM Stage Group Value Setactive4cic2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.2433Deliveryactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.2435HBsAgactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.273Live Birth or Deliveryactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.274Live Birth or Delivery I10active2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.275Live Birth or Deliveryactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.277Deliveryactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.278Delivery - Diagnosisactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.279HBsAgactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.281HBsAgactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.82Deliveryactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.113Chronic kidney disease SCTactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.116DigTx Cognitive Impairment I10active2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.117DigTx Cognitive Impairment SCTactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.124DKDactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.147HFrEF SCTactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.148HFrEF I10active2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.150History of Hypoglycemia I10active2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.151History of Hypoglycemia SCDactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.153Hyperlipidemiaactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.21Thoracic aorta diseaseactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.3Delivery I10active2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.37relatedconditions_hypertension SCTactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.5Delivery - Procedureactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.85PCSK9iactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.88DEPRECATED Diabetesactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.95Albuminuriaactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.96AlcoholicLiverDisease I10active2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.99BMI SCTactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.92ASCVDactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.17Atrial fibrillationactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.45ACE inhibitor allergy RXNORMactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.94Albuminuria SCTactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.35Pressure Ulcer Stageactive2023-07
hl7.fhir.us.vrdrR4ValueSet/vrdr-transportation-incident-role-vsTransportation Incident Role ValueSetactivepher2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.320Opioids ATCPROD N02Aactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.473Tetanus toxoid, diphtheria (Td) Vaccineactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.569Allergen Immunotherapyactive2023-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.976Ensifentrineactive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.977Dupilumabactive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.106Cytochrome P450 2C9 inhibitorsactive2023-10
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.478Allergy to HPV Vaccineactive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.570Allergy to house dust mites SCTactive2023-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.618relatedconditions_Asthma SCTactive2023-09
hl7.fhir.us.vitalsR4ValueSet/BodyTempAssociatedSituationVSBody Temperature Associated Situation value setdraft2024-10